atriopeptin analog I(117038-68-3)
- Name: atriopeptin analog I
- Synonyms:2-24-Atrialnatriuretic peptide-24 (rat reduced), 3-de-L-cysteine-19-de-L-cysteine- (9CI);Atriopeptin-21 (rat reduced), 1-de-L-serine-3-de-L-cysteine-19-de-L-cysteine-21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;312: PN: WO0069900 SEQID: 494 unclaimed sequence; 410: PN: US20090175821 SEQID:494 claimed protein
- Molecular Formula:C98H152 N32 O30
- Molecular Weight:2258.45
- CAS Registry Number:117038-68-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.117038-68-3 atriopeptin analog I
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] 
Assessed
SupplierTel:+86-189 8945 5137
Address:Jian Qiao Community, 789 Shenhua Road, Xihu District, Hangzhou, China, 310000
- Contact Suppliers
Other Product
- 71010-78-1/1-Hexanol, 2-ethyl-, reaction products with 3-methyl-1,1,1,5,5,5-hexakis(1-methylpropoxy)-3-((tris(1-methylpropoxy)silyl)oxy)trisiloxane
- 149471-20-5/5,10,15,21,26-Pentaazahentriacontanoicacid, 31-amino-5,15,26-trihydroxy-4,11,14,22,25-pentaoxo-
- 63019-46-5/Cholesterol 5-methylhexanoate
- 108742-11-6/(1S,2S,3R,5R)-3-(5-amino-7-chloro-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol
- 6848-13-1/3-CHLORO-N,N-DIMETHYLANILINE
- 67204-03-9/CUPRATE(4-), ((4,4,4,4-(21H,23H-PORPHINE-5,10,15,20-TETRAYL)TETRAKIS(BENZE
- 5961-99-9/2-phenylthiochroman
- 79403-55-7/Methyl N-succinimidoxyacetate
- 26950-63-0/1,2-Ethanediamine, N,N-bis(2-aminoethyl)-, polymer with methyloxirane
- 452-64-2/1,2-Dimethyl-4-fluorobenzene
- 138265-88-0/FIREBRAKE(R) ZB
- 107783-56-2/Pyrrolo[2,1-b]quinazolin-9(1H)-one, 2,3-dihydro-3-hydroxy-5-methoxy- (9CI)
- 24519-41-3/6-(4-hydroxyphenyl)-2,3-dihydro-5H-[1,4]dithiino[2,3-c]pyrrole-5,7(6H)-dione
- 61012-91-7/1,4-dibenzyl-2,5-dimethyl-1,2,4,5-tetrazinane
- 68152-88-5/Soybean oil, polymer with pentaerythritol, phthalic anhydride and polymd. soybean oil
- 67627-13-8/tetrahydrocannabinol C4'-glucuronide
- 24499-80-7/5,5-Dimethylhexanoic acid
- 62764-70-9/butyl 4-[(3-oxobutanoyl)amino]benzoate
- 37021-14-0/3-ethyl-1-phenyl-2-thioxoimidazolidin-4-one
- 117038-68-3/atriopeptin analog I
- 25719-60-2/Bicyclo3.1.1heptane, 6,6-dimethyl-2-methylene-, homopolymer
- 14436-34-1/2,4(3H,5H)-Pyrimidinedione, 6-amino- (9CI)
- 84645-52-3/ethyl cyano[4-(2-ethoxy-2-oxoethyl)-3-phenyl-1,3-thiazol-2(3H)-ylidene]acetate
- 73603-52-8/3-acetyl-5-bromo-1,3-benzoxazol-2(3H)-one
- 88612-19-5/4,7-dimethoxy-2-methylquinoline hydrochloride
- 61520-41-0/(2R)-2-[(5alpha,18R)-3-(benzyloxy)-6-methoxy-17-methyl-7,8-didehydro-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-18-yl]hexan-2-ol
- 84392-17-6/4-(Trifluoromethyl)-2'-biphenylcarboxylic acid
- 85909-39-3/sodium 2-ethylhexyl 2-hydroxyethyl phosphate
- 83269-07-2/Carbamic acid, (5-amino-1,2-dihydro-3-(2-naphthalenyl)pyrido(3,4-b)pyr azin-7-yl)-, ethyl ester
- 177344-73-9/Octadecanamide,N-5H-benzo[a]phenoxazin-5- ylidene-